Radiologists Among Docs Most Optimistic About Profession’s Short-Term Future
Radiologists lead physician specialists in short‑term optimism, with 69% viewing the next three years positively, according to Medscape’s 2024 survey of 177 radiologists. That confidence evaporates for the long term, where only 42% remain optimistic—a 27‑point drop that places radiology 18th among specialties. Compensation, work‑life balance and reimbursement drive the short‑term outlook, while only 30% would choose the same practice setting again, highlighting setting‑related concerns. Overall, 73% of physicians would choose medicine again, underscoring strong specialty loyalty.
Motif Neurotech Receives FDA IDE Approval to Initiate RESONATE Trial of Motif XCS System in Treatment-Resistant Depression
Motif Neurotech has secured FDA Investigational Device Exemption (IDE) to launch the RESONATE early feasibility study of its Motif XCS System in patients with treatment‑resistant depression who have failed at least two medications. The trial will monitor 12‑month safety, symptom...
Kingstec Advances Real-Time Medical Asset Tracking
Kingstec Technologies announced the rollout of Technology Trace Inc.’s trevii real‑time medical asset tracking platform at St. Joseph’s Healthcare Hamilton. A year‑long pilot delivered a 100% reconciliation rate and 98% floor‑level location accuracy, demonstrating the system’s reliability. Kingstec acted as the...
Cell, Gene And Specialty Drug Costs Intensify For Health Plans
A new Pharmaceutical Strategies Group survey of 228 benefits executives shows 43% of health plans rank controlling specialty drug costs as their top priority, ahead of total cost of care. Specialty medicines now consume more than half of prescription spending,...
STAT+: Veradermics’ Hair Loss Drug Succeeds in Late-Stage Trial
Veradermics announced that its oral hair loss drug VDPHL01 met primary endpoints in a Phase III trial. Over six months, participants taking the pill grew 30‑33 hairs per square centimeter versus seven in the placebo group. Patient‑reported improvement reached 79‑86%, and...
Zepbound’s and Ozempic’s Greatest Benefit May Be Their Anti-Inflammatory Power
GLP‑1 drugs such as Ozempic and Zepbound are gaining recognition for anti‑inflammatory effects that go beyond weight loss and glucose control. Clinical data show semaglutide reduces C‑reactive protein by about 40% independent of weight loss and improves liver inflammation in...
AstraZeneca Reports FDA Approval of Saphnelo for Systemic Lupus Erythematosus (SLE)
The U.S. Food and Drug Administration has granted approval for AstraZeneca’s Saphnelo autoinjector (anifrolumab, 120 mg weekly) for adult patients with systemic lupus erythematosus (SLE) when used alongside standard of care. The decision follows the Phase III TULIP‑SC trial, which enrolled 367...
Novartis Secures Pair of Regulatory Wins for Skin Disease and Malaria Treatments
Novartis won two regulatory milestones: the European Commission approved its oral BTK inhibitor Rhapsido for adults with chronic spontaneous urticaria who have failed antihistamines, and the World Health Organization granted prequalification to Coartem Baby, an artemether‑lumefantrine formulation for infants weighing 2‑5 kg....
Leiden’s Sensor-Free Microrobots Move Like Living Organisms
Researchers at Leiden University have created soft, chain‑like microrobots that move and adapt without sensors, software, or external control. Each 5 µm segment is linked by 0.5 µm joints and powered solely by an electric field, allowing the robot’s shape to dictate...
New NIHR-Funded TRC for Parkinson’s Disease
The National Institute for Health and Care Research (NIHR) has launched the Parkinson’s disease Translational Research Collaboration (PD‑TRC), the first of eight UK TRCs dedicated to Parkinson’s. Backed by NIHR and four major charities, the hub links 17 centres of...
Lilly Falls on Slower Start for Foundayo versus Wegovy
Eli Lilly’s oral GLP‑1 agonist Foundayo launched in early April with modest uptake, recording 1,390 prescriptions in week 1 and 3,707 in week 2, far below Novo Nordisk’s oral Wegovy, which logged over 3,000 fills in its first days and 18,410 in the second...
As Coordination Grows More Complex, Intelligent Care Is Reshaping the Response
Intelligent care is emerging as a strategic framework that synchronizes people, processes, and technology across health systems. As patient flow becomes increasingly complex, many organizations still lack a unified, real‑time view of capacity, with only 17% reporting enterprise‑wide data visibility....
Florida Delays Children’s Health Insurance Expansion as Uninsured Rate Rises
Florida lawmakers approved a KidCare expansion in 2023 that would extend coverage to more than 40,000 additional children by raising the income threshold to 300% of the federal poverty level. Despite federal approval, the DeSantis administration has not implemented the...
Epic Controls 42% of the US EHR Market. Does that Help or Hurt Interoperability?
Epic controls 42.3% of the 2024 acute‑care EHR market, covering roughly 55% of U.S. hospital beds. The vendor’s open‑API strategy now supports over 2,500 third‑party apps and processes 252 billion transactions annually, while its Care Everywhere network moves 27 million charts each...
The Help That Many Older Americans Need Most
Community health workers (CHWs) are increasingly deployed in rural Oregon and Washington to address non‑medical needs of frail older adults, from transportation to housing assistance. A 90‑day pilot program, Connected Care for Older Adults, costs $1,500 per patient and has...
Why Health Plans Are Missing One of Their Most Costly Care Categories
Preference‑sensitive surgeries such as spine fusions, cataract procedures and hip replacements now represent roughly 30% of health‑plan medical spend and are growing 4‑6% annually. Up to 30% of these operations are medically inappropriate, costing commercial plans about $39 million and Medicare...
BrioHealth Secures FDA Approval to Launch BrioVAD System Trial
BrioHealth Solutions received conditional FDA approval to launch the Brio4Kids trial, testing its BrioVAD left ventricular assist device in children with advanced heart failure. Enrollment in the U.S. study is slated for mid‑2026, with initial data expected in the fourth...
Kyowa Kirin and Kura Initiate Phase II Trial of Ziftomenib for AML
Kyowa Kirin and Kura Oncology have opened a Japanese Phase II registrational study of the oral menin inhibitor ziftomenib in adults with relapsed or refractory NPM1‑mutated acute myeloid leukaemia. The single‑arm, open‑label trial will measure a composite complete remission rate (CR + CRh) as...
Review Questions Benefits of Anti-Amyloid Alzheimer’s Drugs
A Cochrane review of 17 clinical trials involving 20,342 patients with early Alzheimer’s disease found that anti‑amyloid drugs provide no clinically meaningful benefit on cognitive decline or dementia severity. The analysis also highlighted an increased risk of brain swelling and...
Sanofi Reports the CHMP Positive Opinion for Cenrifki (Tolebrutinib) to Treat Non-Relapsing SPMS
Sanofi’s oral BTK inhibitor Cenrifki (tolebrutinib) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for treating secondary progressive multiple sclerosis (SPMS) without relapses in the past two years. The recommendation is...
Why “More Doctors” Won’t Fix the Provider Shortage
The United States faces a health‑care provider shortage, but adding more physicians alone won’t solve it. The article argues that regulatory and reimbursement structures limit the contributions of nurses, counselors, community health workers, and other allied professionals who are already...
AI in Single-Cell Analysis: Solving the Interpretation Gap
Single‑cell omics drives drug discovery but interpreting cell‑state annotations remains a bottleneck. Nygen Analytics introduced CyteType, an AI‑augmented platform that adds a traceable interpretation layer to existing pipelines, converting raw clusters into biologically meaningful labels. By combining marker‑gene analysis, literature...
Invest in the Future of Cancer Diagnostics and Treatment
Cancer incidence is rising as populations age and obesity increases, prompting a shift toward proactive diagnostics. Researchers are advancing liquid‑biopsy technologies, especially multi‑omics MCED tests, to detect tumors earlier and with greater specificity. Simultaneously, AI‑enhanced imaging is slashing MRI scan...
Exclusive Human Milk Diet Benefits Very Low Birth Weight Infants
A phase III randomized controlled trial in Japan demonstrated that an exclusive human milk diet markedly improves growth velocity and reduces serious complications in very low birth weight (VLBW) infants compared with mixed feeding regimens. The study eliminated bovine‑based protein fortifiers,...
Feature: Strengthening Patient Understanding Through Digital Consent and Patient Information
Radar Healthcare’s Digital Consent platform replaces paper‑based forms with regulated, electronic workflows, delivering consistent, auditable patient consent. The solution pairs with EIDO Patient Information, a standardized library endorsed by the High Court and Royal Colleges, to provide clear, multi‑language content....
Novartis’ Itvisma Receives the CHMP Positive Opinion for Spinal Muscular Atrophy
Novartis’ gene‑replacement therapy Itvisma (onasemnogene abeparvovec) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for treating patients aged two years and older with 5q spinal muscular atrophy (SMA). The recommendation is...
Disruptions in Medicare Advantage Coverage in 2026
A new study reveals that forced disenrollment from Medicare Advantage (MA) plans will spike to about 10% in 2026, affecting roughly 2.9 million beneficiaries nationwide. In Vermont, 92% of MA enrollees are already facing plan exits, the highest state concentration. The...
NIHR Innovation Programme Offers Funding for Preventative Technologies in Community Care
The NIHR Invention for Innovation Funding at the Speed of Translation (FAST) programme is offering grants of £50,000‑£100,000 (≈$62,500‑$125,000) over six to twelve months for preventative technologies in community care. The funding targets solutions that can be integrated into neighbourhood...
Smart T-Shirt Piloted at Leicester to Support Diagnosis of Breathing Pattern Disorders
A pilot in Leicester is testing Atride’s Anasa® Smart Shirt, a wearable t‑shirt that embeds nanotech sensors to continuously monitor breathing patterns. The device’s data will be benchmarked against the current gold‑standard motion‑capture photography to assess accuracy for diagnosing breathing...
Evonik: €80m for Biopharma CDMO Capacity in Slovakia
Evonik Industries is allocating roughly €80 million (about $87 million) to expand its fermentation plant in Slovenská Ľupča, Slovakia. The investment adds downstream capacity for pharmaceutical active ingredients and creates around 50 new jobs. The site, already a biotech hub producing spider‑silk protein...
Home Blood Pressure Checks Could Reduce Risks After Hypertensive Pregnancy
Researchers at Oxford found that daily home blood‑pressure monitoring combined with rapid medication adjustments improves arterial health in new mothers who experienced hypertensive pregnancies. In a trial of 220 women, those using a home monitor and app showed less arterial...
San Juan Launches ‘Ligtas Tigdas’ Drive for World Immunization Week 2026
San Juan City marked World Immunization Week 2026 by launching the “Ligtas Tigdas” drive, vaccinating roughly 250 residents with routine, HPV and tetanus‑diphtheria shots. The campaign targeted infants, Grade IV students, pregnant women and families needing catch‑up doses, and featured health‑education booths to...
EClinicalWorks Launches Healow CCM Specialist Service to Automate Monthly Patient Outreach and Documentation
eClinicalWorks has launched the healow Chronic Care Management (CCM) Specialist Service, a specialist‑as‑a‑service model that embeds certified clinicians into ambulatory practice workflows. The service handles monthly outreach, prescription follow‑ups and care‑plan reviews, automatically documenting calls in the EHR for Medicare...
Turn Health Data Into Impact: Browns University's Online Master in Biostatistics & Health Data Science
Brown University has launched an online Master’s in Biostatistics with a concentration in Health Data Science, delivered through its School of Public Health and School of Professional Studies. The 20‑month, five‑semester program comprises nine courses and a capstone project that...
Antibiotics for Acne: How Much Is Too Much?
Antibiotics can be effective for moderate‑to‑severe inflammatory acne, but they are intended for short‑term use. Oral agents such as doxycycline are typically limited to two or three months, while topical antibiotics may be used longer when combined with other therapies....
In the Land of the Unblind: Are Psychedelics Really Better than Antidepressants?
Recent meta‑analysis comparing psychedelic‑assisted therapy (PAT) with open‑label antidepressant trials finds no clinically important difference in depression outcomes. While early PAT studies suggested larger effects, the analysis shows that functional unblinding limits any advantage, and open‑label antidepressants marginally outperform blinded...
Multimorbidity Patterns Linked to Elderly Mortality Risk
A new BMC Geriatrics study of over 5,000 Shenzhen seniors links specific multimorbidity clusters to markedly higher mortality risk. Researchers used big‑data analytics and cluster‑analysis to identify patterns, finding that combinations of cardiovascular disease, diabetes and chronic respiratory illness produce...
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices
Murata Manufacturing has begun mass production of two new anisotropic magnetoresistance (AMR) sensors, the MRMS166R and MRMS168R. The MRMS166R achieves a record‑low average current draw of 20 nA while operating from a 1.2 V supply, and the MRMS168R provides up to 12 mA...
Current Political Climate Having 'Detrimental' Effect on Radiology Research, Survey Says
A recent survey published in Clinical Imaging finds that policies enacted by the Trump administration have created a hostile environment for radiology research. More than 70% of 176 authors from top radiology journals report that securing funding has become harder,...
Secretome-Mediated Antimicrobial and Immunomodulatory Activity of Lactobacillus Johnsonii Against Multidrug-Resistant Enteroaggregative Escherichia Coli
Researchers evaluated Lactobacillus johnsonii as a probiotic against a multidrug‑resistant enteroaggregative E. coli (EAEC) strain. The bacterium showed strong gastrointestinal tolerance, high auto‑aggregation (80 % at 4 h), and secretome‑driven inhibition of EAEC growth and biofilm formation, surpassing gentamicin. It also reduced...
South Korea’s MFDS Reiterates Ban on Gymnema Sylvestre, Bacopa in Supplements
South Korea’s Ministry of Food and Drug Safety (MFDS) has reaffirmed its ban on several botanicals and pharmaceutical compounds, including Gymnema sylvestre and Bacopa, after finding them in 18 of 30 overseas‑made health supplements sold via Amazon, eBay and other...
Children and Adolescents From Socioeconomically Disadvantaged Areas Face Barriers to Accessing Mental Health Services
Researchers at the University of Nottingham published a longitudinal analysis of the STADIA trial, tracking 1,225 children referred to England's child and adolescent mental health services (CAMHS). The study found that youths from the most socio‑economically deprived neighborhoods were significantly...
Why Some Hospitals Are Betting on Midstream Health to Help Eliminate Waste
Midstream Health, a San Francisco AI startup founded in 2023, helps hospitals slash expenses by consolidating fragmented financial and operational data. Its platform uncovers missed rebates, prevents over‑paying for supplies, and streamlines contract verification. Major systems such as Mount Sinai,...
Morning Headlines 4/27/26
HIStalk’s morning briefing highlighted several disparate issues: the ethical and legal pitfalls of paying informants, noting that funds rarely reach the target organization; the success of an anti‑hate nonprofit that financed undercover operatives to dismantle KKK cells; a critique of...
Investment in UK Biotechs Shows Early Signs of Recovery, Report Says
Investment in UK biotechnology firms is rebounding after a mid‑2025 slowdown, according to the BioIndustry Association. In the first quarter of 2026, equity funding reached roughly $210 million, a 75% year‑over‑year rise. The number of deals climbed to 48, and the...
Femoral Fracture Patterns Reveal Southern Brazil Inequalities
A new study mapping femoral fractures among Brazil's elderly reveals stark regional gaps. Areas with dense orthopedic services report fewer fractures and complications, while remote, low‑income zones experience delayed care and higher infection rates. Seasonal analysis shows peaks during colder,...
Eli Lilly and Company (LLY): Among the Best Stocks to Buy While the Market Is Down
Eli Lilly announced a strategic acquisition of Kelonia Therapeutics for up to $7 billion, with $3.25 billion paid upfront and up to $3.75 billion in milestones. Kelonia’s in‑body CAR‑T platform, led by Phase 1 candidate KLN‑1010, expands Lilly’s oncology pipeline beyond its dominant weight‑loss franchise....
Hospital's Poor Radiation Safety Protocols Led to Cancer 'Cluster' Among Staff, Rad Tech Claims
A former radiologic technologist at University Malaya Medical Center (UMMC) in Kuala Lumpur has sued the hospital, alleging that inadequate radiation safety protocols after installing a new PET scanner caused a cluster of cancer cases among staff. The claimant, Nur...
Working to Reduce Low-Value Preoperative Testing in Michigan
A new study by Michigan Medicine’s MPrOVE program revealed that pre‑operative testing rates for low‑risk surgeries varied dramatically across the state, ranging from 8% to 88%. By analyzing local data, the team identified that Michigan Medicine was in the top...
New Guidelines Recommend Mammograms Every 2 Years for Older Women
The American College of Physicians (ACP) issued new guidance urging biennial mammography for average‑risk women aged 50 to 74, shifting away from annual screening. For women 40‑49, the ACP advises shared‑decision making rather than routine exams, and it recommends discontinuing...